Dendritic cell trafficking and antigen presentation in the human immune response to Mycobacterium tuberculosis

Journal of Immunology

Volumn 173, Issue 1, 2004, Pages 494-506

  Marino, Simeone ^a   Pawar, Santosh ^b   Fuller, Craig L ^c   Reinhart, Todd A ^c   Flynn, JoAnne L ^b   Kirschner, Denise E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; BACTERIAL STRAIN; BRONCHOSCOPY; CELL ACTIVATION; CELL COUNT; CELL MIGRATION; CELL TRANSPORT; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; IMMUNE RESPONSE; IMMUNITY; LATENT PERIOD; LYMPH NODE; MACACA; MATHEMATICAL MODEL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TUBERCULOSIS;

EID: 2942731611     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.1.494     Document Type: Article

References (107)

1. Arend, S. M., and J. T. van Dissel. 2002. Evidence of endogenous reactivation of tuberculosis after a long period of latency. J. Infect. Dis. 186:876.
2. Lillebaek, T., A. Dirksen, I. Baess, B. Strunge, V. O. Thomsen, and A. B. Andersen. 2002. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J. Infect. Dis. 185:401.
3. Flynn, J. L., and J. Chan. 2001. Tuberculosis: latency and reactivation. Infect. Immun. 69:4195.
4. Tufariello, J. M., J. Chan, and J. L. Flynn. 2003. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect. Dis. 3:578.
5. Styblo, K. 1980. Recent advances in epidemiological research in tuberculosis. Adv. Tuberc. Res. 20:1.
6. Comstock, G. W., V. T. Livesay, and S. F. Woolpert. 1974. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am. J. Epidemiol. 99:131.
7. Bloom, B. R. 1994. Tuberculosis: Pathogenesis, Protection, and Control. Am. Soc. Microbiol., Washington, DC.
8. Bottomly, K. 1999. T cells and dendritic cells get intimate. Science 283:1124.
9. Lanzavecchia, A., and F. Sallusto. 2000. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290:92.
10. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255.
11. + subclasses of dendritic cells undergo phenotypic and functional maturation in vitro and in vivo. J. Leukocyte Biol. 69:951.
12. Grabbe, S., E. Kampgen, and G. Schuler. 2000. Dendritic cells: multi-lineal and multi-functional. Immunol. Today 21:431.
13. Liu, Y. J., N. Kadowaki, M. C. Rissoan, and V. Soumelis. 2000. T cell activation and polarization by DC1 and DC2. Curr. Top. Microbiol. Immunol. 251:149.
14. - dendritic cells in the induction of primary immune responses in vivo. J. Leukocyte Biol. 66:242.
15. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189:587.
16. Maldonado-Lopez, R., and M. Moser. 2001. Dendritic cell subsets and the regulation of Th1/Th2 responses. Semin. Immunol. 13:275.
17. - dendritic cells to prime Th1/Th2 cells in vivo. J. Immunol. 167:4345.
18. Moser, M., and K. M. Murphy. 2000. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 1:199.
19. Pulendran, B., J. L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky, and C. R. Maliszewski. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96:1036.
20. Rissoan, M. C., V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, R. de Waal Malefyt, and Y. J. Liu. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183.
21. - dendritic cells. J. Immunol. 167:4215.
22. Medzhitov, R., and C. A. Janeway, Jr. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91:295.
23. Arriaga, A. K., E. H. Orozco, L. D. Aguilar, G. A. Rook, and R. Hernandez Pando. 2002. Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clin. Exp. Immunolo. 128:229.
24. Matzinger, P. 2002. An innate sense of danger. Ann. NY Acad. Sci. 961:341.
25. Matzinger, P. 2002. The danger model: a renewed sense of self. Science 296:301.
26. Rescigno, M., and P. Borrow. 2001. The host-pathogen interaction: new themes from dendritic cell biology. Cell 106:267.
27. Rescigno, M. 2002. Dendritic cells and the complexity of microbial infection. Trends Microbiol. 10:425.
28. Rescigno, M., M. Urbano, M. Rimoldi, B. Valzasina, G. Rotta, F. Granucci, and P. Ricciardi-Castagnoli. 2002. Toll-like receptor 4 is not required for the full maturation of dendritic cells or for the degradation of Gram-negative bacteria. Eur. J. Immunol. 32:2800.
29. Fernandez, N. C., C. Flament, F. Crepineau, E. Angevin, E. Vivier, and L. Zitvogel. 2002. Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk. Eur. Cytokine Netw. 13:17.
30. Gallucci, S., M. Lolkema, and P. Matzinger. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5:1249.
31. Reis e Sousa, C. 2001. Dendritic cells as sensors of infection. Immunity 14:495.
32. Pulendran, B., K. Palucka, and J. Banchereau. 2001. Sensing pathogens and tuning immune responses. Science 293:253.
33. Kalinski, P., C. M. Hilkens, E. A. Wierenga, and M. L. Kapsenberg. 1999. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20:561.
34. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93.
35. Giacomini, E., E. Iona, L. Ferroni, M. Miettinen, L. Fattorini, G. Orefici, I. Julkunen, and E. M. Coccia. 2001. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J. Immunol. 166:7033.
36. + T cells with specificity for a novel mycobacterial epitope. Int. Immunol. 13:451.
37. Bodnar, K. A., N. V. Serbina, and J. L. Flynn. 2001. Fate of Mycobacterium tuberculosis within murine dendritic cells. Infect. Immun. 69:800.
38. Demangel, C., and W. J. Britton. 2000. Interaction of dendritic cells with mycobacteria: where the action starts. Immunol. Cell Biol. 78:318.
39. Hickman, S. P., J. Chan, and P. Salgame. 2002. Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naive T cell polarization. J. Immunol. 168:4636.
40. Jiao, X., R. Lo-Man, P. Guermonprez, L. Fiette, E. Deriaud, S. Burgaud, B. Gicquel, N. Winter, and C. Leclerc. 2002. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J. Immunol. 168:1294.
41. Holt, P. G., and M. A. Schon-Hegrad. 1987. Localization of T cells, macrophages and dendritic cells in rat respiratory tract tissue: implications for immune function studies. Immunology 62:349.
42. Holt, P. G., J. Oliver, N. Bilyk, C. McMenamin, P. G. McMenamin, G. Kraal, and T. Thepen. 1993. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J. Exp. Med. 177:397.
43. Holt, P. G. 2000. Antigen presentation in the lung. Am. J. Respir. Crit. Care Med. 162:S151.
44. Sertl, K., T. Takemura, E. Tschachler, V. J. Ferrans, M. A. Kaliner, and E. M. Shevach. 1986. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J. Exp. Med. 163:436.
45. van Haarst, J. M., H. J. de Wit, H. A. Drexhage, and H. C. Hoogsteden. 1994. Distribution and immunophenotype of mononuclear phagocytes and dendritic cells in the human lung. Am. J. Respir. Cell Mol. Biol. 10:487.
46. Guermonprez, P., J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621.
47. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
48. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
49. Gonzalez-Juarrero, M., and I. M. Orme. 2001. Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis. Infect. Immun. 69:1127.
50. Havenith, C. E., A. J. Breedijk, and E. C. Hoefsmit. 1992. Effect of bacillus Calmette-Guérin inoculation on numbers of dendritic cells in bronchoalveolar lavages of rats. Immunobiology 184:336.
51. Henderson, R. A., S. C. Watkins, and J.L. Flynn. 1997. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 159:635.
52. Palucka, K., and J. Banchereau. 1999. Linking innate and adaptive immunity. Nat. Med. 5:868.
53. Choi, Y. K., B. A. Fallert, M. A. Murphey-Corb, and T. A. Reinhart. 2002. Simian immunodeficiency virus dramatically alters expression of homeostatic chemokines and dendritic cell markers during infection in vivo. Blood 24:24.
54. Sallusto, F., P. Schaerli, P. Loetscher, C. Schaniel, D. Lenig, C. R. Mackay, S. Qin, and A. Lanzavecchia. 1998. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28:2760.
55. Lanzavecchia, A., and F. Sallusto. 2001. Regulation of T cell immunity by dendritic cells. Cell 106:263.
56. Lanzavecchia, A. 1999. Dendritic cell maturation and generation of immune responses. Haematologica 84(Suppl. EHA-4):23.
57. Janeway, C. 2001. Immunobiology 5: The Immune System in Health and Disease. Garland, New York.
58. Zhu, K., Q. Shen, M. Ulrich, and M. Zheng. 2000. Human monocyte-derived dendritic cells expressing both chemotactic cytokines IL-8, MCP-1, RANTES and their receptors, and their selective migration to these chemokines. Chim. Med. J. (Engl.) 113:1124.
59. Adema, G. J., F. Hartgers, R. Verstraten, E. de Vries, G. Marland, S. Menon, J. Foster, Y. Xu, P. Nooyen, T. McClanahan, et al. 1997. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387:713.
60. DesJardin, L. E., T. M. Kaufman, B. Potts, B. Kutzbach, H. Yi, and L. S. Schlesinger. 2002. Mycobacterium tuberculosis-infected human macrophages exhibit enhanced cellular adhesion with increased expression of LFA-1 and ICAM-1 and reduced expression and/or function of complement receptors, FcγRII and the mannose receptor. Microbiology 148:3161.
61. Russo, D. M., N. Kozlova, D. L. Lakey, and D. Kernodle. 2000. Naive human T cells develop into Th1 effectors after stimulation with Mycobacterium tuberculosis-infected macrophages or recombinant Ag85 proteins. Infect. Immun. 68:6826.
62. Langenkamp, A., M. Messi, A. Lanzavecchia, and F. Sallusto. 2000. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 1:311.
63. Fortsch, D., M. Rollinghoff, and S. Stenger. 2000. IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J. Immunol. 165:978.
64. Palucka, K. A., N. Taquet, F. Sanchez-Chapuis, and J. C. Gluckman. 1998. Dendritic cells as the terminal stage of monocyte differentiation. J. Immunol. 160:4587.
65. Marino, S., and D. E. Kirschner. 2004. The human immune response to Mycobacterium tuberculosis in lung and lymph node. J. Theor. Biol. 227:463.
66. Flynn, J. L., S. V. Capuano, D. Croix, S. Pawar, A. Myers, A. Zinovik, and E. Klein. 2003. Non-human primates: a model for tuberculosis research. Tuberculosis (Edinb.) 83:116.
67. Capuano, S. V. III, D. A. Croix, S. Pawar, A. Zinovik, A. Myers, P. L. Lin, S. Bissel, C. Fuhrman, E. Klein, and J. L. Flynn. 2003. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect. Immun. 71:5831.
68. Gammack, D., C. R. Doering, and D. E. Kirschner. 2004. Macrophage response to Mycobacterium tuberculosis infection. J. Math. Biol. 48:218.
69. Croix, D. A., S. Capuano III, L. Simpson, B. A. Fallert, C. L. Fuller, E. C. Klein, T. A. Reinhart, M. Murphey-Corb, and J. L. Flynn. 2000. Effect of mycobacterial infection on virus loads and disease progression in simian immunodeficiency virus-infected rhesus monkeys. AIDS Res. Hum. Retroviruses 16:1895.
70. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708.
71. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 2000. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18:593.
72. Sallusto, F., and A. Lanzavecchia. 2000. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immanol. Rev. 177:134.
73. + T cells in tuberculosis. Am. J. Respir. Crit. Care Med. 166:1116.
74. + CTL from lungs of Mycobacterium tuberculosis-infected mice express perform in vivo and lyse infected macrophages. J. Immunol. 165:353.
75. + T cells participate in the memory immune response to Mycobacterium tuberculosis. Infect. Immun. 69:4320.
76. Blower, S. M., and H. Dowlatabadi. 1994. Sensitivity and uncertainty analysis of complex-models of disease transmission: an HIV model, as an example. Int. Stat. Rev. 62:229.
77. Greenland, S. 2001. Sensitivity analysis, Monte Carlo risk analysis, and Bayesian uncertainty assessment. Risk Anal. 21:579.
78. Helton, J. C., and F. J. Davis. 2002. Illustration of sampling-based methods for uncertainty and sensitivity analysis. Risk Anal. 22:591.
79. Sanchez, M. A., and S. M. Blower. 1997. Uncertainty and sensitivity analysis of the basic reproductive rate: tuberculosis as an example. Am. J. Epidemiol. 145:1127.
80. Harbeck, R. J. 1998. Immunophenotyping of bronchoalveolar lavage lymphocytes. Clin. Diagn. Lab. Immunol. 5:271.
81. Goldstein, R. A., P. K. Rohatgi, E. H. Bergofsky, E. R. Block, R. P. Daniele, D. R. Dantzker, G. S. Davis, G. W. Hunninghake, T. E. King, Jr., W. J. Metzger, et al. 1990. Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am. Rev. Respir. Dis. 142:481.
82. 1989. Technical recommendations and guidelines for bronchoalveolar lavage (BAL): Report of the European Society of Pneumology Task Group. Eur. Respir. J. 2:561.
83. Choi, M. S., J. H. Lee, K. C. Koh, S. W. Paik, P. L. Rhee, J. J. Kim, J. C. Rhee, K. W. Choi, and S. H. Kim. 2001. Clinical significance of enlarged perihepatic lymph nodes in chronic hepatitis B. J. Clin. Gastroenterol. 32:329.
84. Condos, R., W. N. Rom, Y. M. Liu, and N. W. Schluger. 1998. Local immune responses correlate with presentation and outcome in tuberculosis. Am. J. Respir. Crit. Care Med. 157:729.
85. Taha, R. A., T. C. Kotsimbos, Y. L. Song, D. Menzies, and Q. Hamid. 1997. IFN-γ and IL-12 are increased in active compared with inactive tuberculosis. Am. J. Respir. Crit. Care Med. 155:1135.
86. Taha, R. A., E. M. Minshall, R. Olivenstein, D. Ihaku, B. Wallaert, A. Tsicopoulos, A. B. Tonnel, R. Damia, D. Menzies, and Q. A. Hamid. 1999. Increased expression of IL-12 receptor mRNA in active pulmonary tuberculosis and sarcoidosis. Am. J. Respir. Crit. Care Med. 160:1119.
87. Barnes, P. F., S. Lu, J. S. Abrams, E. Wang, M. Yamamura, and R. L. Modlin. 1993. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61:3482.
88. O'Doherty, U., M. Peng, S. Gezelter, W. J. Swiggard, M. Betjes, N. Bhardwaj, and R. M. Steinman. 1994. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 82:487.
89. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon-γ gene-disrupted mice. J. Exp. Med. 178:2243.
90. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249.
91. Holland, S. M., S. E. Dorman, A. Kwon, I. F. Pitha-Rowe, D. M. Frucht, S. M. Gerstberger, G. J. Noel, P. Vesterhus, M. R. Brown, and T. A. Fleisher. 1998. Abnormal regulation of interferon-γ, interleukin-12, and tumor necrosis factor-α in human interferon-γ receptor 1 deficiency. J. Infect. Dis. 178:1095.
92. Newport, M. J., C. M. Huxley, S. Huston, C. M. Hawrylowicz, B. A. Oostra, R. Williamson, and M. Levin. 1996. A mutation in the interferon-γ- receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941.
93. Murray, P. J., and R. A. Young. 1999. Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect. Immun. 67:3087.
94. Wigginton, J. E., and D. Kirschner. 2001. A model to predict cell-mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis. J. Immunol. 166:1951.
95. Bonecini-Almeida, M. G., S. Chitale, I. Boutsikakis, J. Geng, H. Doo, S. He, and J. L. Ho. 1998. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-γ and primed lymphocytes. J. Immunol. 160:4490.
96. Caruso, A. M., N. Serbina, E. Klein, K. Triebold, B. R. Bloom, and J. L. Flynn. 1999. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to tuberculosis. J. Immunol. 162:5407.
97. Flynn, J. L., and J. D. Ernst. 2000. Immune responses in tuberculosis. Curr. Opin. Immunol. 12:432.
98. Lazarevic, V., A. J. Myers, C. A. Scanga, and J. L. Flynn. 2003. CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection. Immunity 19:823.
99. Li, Y. J., M. Petrofsky, and L. E. Bermudez. 2002. Mycobacterium tuberculosis uptake by recipient host macrophages is influenced by environmental conditions in the granuloma of the infectious individual and is associated with impaired production of interleukin-12 and tumor necrosis factor-α. Infect. Immun. 70:6223.
100. Tailleux, L., O. Schwartz, J. L. Herrmann, E. Pivert, M. Jackson, A. Amara, L. Legres, D. Dreher, L. P. Nicod, J. C. Gluckman, et al. 2003. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 197:121.
101. Schlesinger, L. S. 1993. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150:2920.
102. Iseman, M. D. 2002. Tuberculosis therapy: past, present and future. Eur. Respir. J. Suppl. 36:87s.
103. Iseman, M. D. 2000. A Clinician's Guide to Tuberculosis. Lippincott Williams & Wilkins, Philadelphia.
104. International Union against Tuberculosis and Lung Disease, World Conference, and M. D. Iseman. 1999. Update treatment of multidrug-resistant tuberculosis: proceedings of a sponsored symposium to the 29th World Conference of the International Union against Tuberculosis and Lung Diseases (IUATLD/UICTMR): Bangkok, Thailand, November 24, 1998. Karger, Basel.
105. Orme, I. M., D. N. McMurray, and J. T. Belisle. 2001. Tuberculosis vaccine development: recent progress. Trends Microbiol. 9:115.
106. Iseman, M. D. 2000. TB elimination in the 21st century, a quixotic dream? Int. J. Tuberc. Lung Dis. 4:S109.
107. Iseman, M. D. 2000. Tuberculosis: still the #1 killer in infectious diseases. Int. J. Clin. Pract. Suppl. 78.